India to Philippines: Irbesartan Export Trade Route

The India to Philippines Irbesartan corridor is one of India's established pharmaceutical export routes, with 171 shipments documented worth a combined $4.1M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's irbesartan manufacturing sector.

Across 21 active suppliers, the average shipment value stands at $23.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 19.4%, placing it at rank #2 among India's top irbesartan export destinations globally.

On the import side, key buyers of Indian irbesartan in Philippines include ONE DEXCEL PHARMA INC., ZYDUS HEALTHCARE PHILIPPINES INC., TO THE ORDER and 31 others. ONE DEXCEL PHARMA INC. is the single largest importer with 16 shipments valued at $562.5K USD.

India's irbesartan exports to Philippines are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 32 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 21 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, ZYDUS LIFESCIENCES LIMITED, GLOBELA PHARMA PRIVATE LIMITED — together account for 61% of total trade value on this route. The average shipment value of $23.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharm drug&med:virbez 300 (irbesartan 300mg tablets each film coated tablet cont:irbesartan ph.eur. 300 mg(asperinv) and pharm drug&med:virbez 300(irbesartan 300mg tab each film coated tablet cont:irbesartan ph.eur 300mg col:titani(asperinv)nos, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ONE DEXCEL PHARMA INC. is the largest importer with 16 shipments worth $562.5K USD — representing 14% of all irbesartan imports from India on this route. A total of 34 buyers are active on this corridor.